Ledger.Open graph →
SEC Form D · filed June 7, 2021

Dianthus Therapeutics, Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Tomas E. Kiselak · Waltham, MADirectorJonathan E. Violin · Waltham, MAExec · DirectorLeon O. Moulder, Jr · Waltham, MADirectorKenneth E. Thompson · Waltham, MAExecJoni Creighton · Flagler, CODirectorWinifred Walters · Flagler, COExecMatthew Topliff · Malvern, PADirectorJason Keiser · Malvern, PAExec · DirectorRoss Buhrdorf · Austin, TXDirectorJenne Britell · Austin, TXExec · DirectorPorter Lummus · Atlanta, GADirectorStephen D. Reynolds · Coral Gables, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗